Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioImagene Inc. to Present at Medtech Insight and Windhover Information's ``Investment In Innovation (In3) WEST'' Conference, February 23-24, 2006, Irvine, CA.


IRVINE, Calif. -- BioImagene Inc. has announced that it will be presenting on 23rd Feb. '06 at Medtech Insight and Windhover wind·hov·er  
n. Chiefly British
A kestrel.
 Information's "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies" Conference, Feb. 23-24, 2006, at the Hyatt Regency Regency, in British history, the period of the last nine years (1811–20) of the reign of George III, when the king's insanity had rendered him unfit to rule and the government was vested in the prince of Wales (later George IV) as regent.  Irvine in Irvine, Calif.

BioImagene Inc. is a leading company pioneering a new generation of image informatics Same as information technology and information systems. The term is more widely used in Europe.  solutions targeted to the specific needs of the life science research and medical diagnostic workspace. BioImagene provides sophisticated Bio-Image Analysis & Management products built on the technology platforms SIMS SIMS Secondary Ion Mass Spectrometry
SIMS School of Information Management and Systems
SIMS Sun Internet Mail Server
SIMS Student Information Management System
SIMS Steacie Institute for Molecular Sciences (National Research Council, Canada) 
(TM) & iHarness(TM). BioImagene's products allow pathologists to effectively analyze and manage tissue image data. These web-based automated informatics tools provide consistent, reproducible and objective analysis of tissue images, while support storage, retrieval and data sharing The ability to share the same data resource with multiple applications or users. It implies that the data are stored in one or more servers in the network and that there is some software locking mechanism that prevents the same set of data from being changed by two people at the same time.  for peer review, improving the standard of patient care and increasing the speed of drug discovery.

Tissue analysis forms the core component of the drug development cycles, from target identification, lead validation and clinical trials to Tox-Path screenings and disease diagnosis. More than 70% of the pathological 1. pathological - [scientific computation] Used of a data set that is grossly atypical of normal expected input, especially one that exposes a weakness or bug in whatever algorithm one is using.  data is in form of tissue images. Despite the technological advancements, the pathological evaluation of thousands of tissues samples still remains very manual: pathologists still spend hundreds of hours looking at a glass slide to make a diagnosis. A huge increase in the drug candidates entering development and the specimens for evaluation has led to a growing need for a comprehensive approach to pathology evaluation called 'Digital Pathology.'

TissueMine(TM), a tissue-informatics application from BioImagene, caters to the industry bottlenecks by facilitating automation and standardization standardization

In industry, the development and application of standards that make it possible to manufacture a large volume of interchangeable parts. Standardization may focus on engineering standards, such as properties of materials, fits and tolerances, and drafting
 of evaluation of histopathological tissue specimen images, assisting pathologists to direct their efforts on more challenging areas of abnormalities. Its self-learning engine analyzes image using color, intensity, and morphological mor·phol·o·gy  
n. pl. mor·phol·o·gies
1.
a. The branch of biology that deals with the form and structure of organisms without consideration of function.

b.
 patterns. The web-based architecture helps the community to share the information in a more effective way and for cost-efficient statistical analysis. Twelve of the world's leading pharmaceuticals are successfully using our solutions. The application can analyze the slides of tissue sections stained for various biomarkers, and can store and manage this image data for peer review and consultation. Importantly, these systems are also hardware independent, and can be customized as per the existing workflow.

At BioImagene we believe that Digital Pathology is the next big frontier of unexplored opportunities in an untapped market, and we are well positioned to lead that wave with focus on "Pathology Imaging."

A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. In3 WEST is Medtech Insight's 20th investment and partnering event to date. To register to attend or for more information on Medtech Insight, please call Kristy Grimes Grimes is a surname, that is believed to be of a Scandinavian decent and may refer to
  • Aoibhinn Grimes
  • Ashley Grimes
  • Barbara Grimes, a Chicago murder victim
  • Burleigh Grimes (1893–1985), US baseball player
  • Camryn Grimes
  • Charles Grimes
 at 480-985-9512 or 888-202-5939 toll-free in the U.S., e-mail kristy@medtechinsight.com, or visit www.medtechinsight.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 17, 2006
Words:458
Previous Article:Open Ratings Powers Eaton's Supplier Risk Strategy; Executive Dashboard Core to Enterprise Risk Management.
Next Article:Music Industry Executive Tommy Nast Appointed Executive Vice President, Business Development for CenterStaging Musical Productions, Inc.
Topics:



Related Articles
Medtech Insight and Windhover Information Announce the 'In3 WEST' Early-Stage Medical Technology Investment and Partnering Conference, Feb. 23-24,...
Medtech Insight's 20th Medical Technology Investment and Partnering Event, 'In3 WEST,' to Feature 50 Emerging Medical Technology Companies Seeking...
Emerging Cardiovascular, Orthopedics/Spine, Stroke, Drug Delivery, Pharma, Diagnostics and Diabetes Companies Among the 50 Presenters at Medtech...
50 Innovative Emerging Medical Technology Companies Seeking Funding and/or Strategic Partnership to Present at Medtech Insight's 'In3 WEST'...
40 Early-Stage Medical Technology Companies Confirmed to Date to Present at Medtech Insight's 'In3 WEST' Investment and Partnering Conference, Feb....
42 Emerging Medical Technology Companies Seeking Funding and/or Strategic Partnership Confirmed to Date to Present at Medtech Insight's 'In3 WEST'...
Early-Stage Cardiovascular, Orthopedics/Spine, Ophthalmology, Imaging, and Regenerative Medicine Companies among the 50 Presenters at Medtech Insight...
Prominent Senior Executives from Stryker, St. Jude Medical, and Edwards Lifesciences Participating in Panel Discussion Titled 'The Big Company...
FINAL ANNOUNCEMENT: Medtech Insight and Windhover Information's 'Investment In Innovation (In3) WEST' Early-Stage Medical Technology Investment and...
Hear Presentations from Nearly 40 Early-Stage Cardiovascular, Spine/Orthopedics, Biotechnology and Other Emerging Medical Technology Companies from...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles